Dr. J. Randolph Hecht, MD
Claim this profileUCLA Medical Center
Studies Pancreatic Cancer
Studies Lung Cancer
5 reported clinical trials
7 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
HLA-A positive
2Lung Cancer
Stage III
Stage IV
HLA-A positive
Affiliated Hospitals
Clinical Trials J. Randolph Hecht, MD is currently running
CAR T-Cell Preparation
for Cancer
Objective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect and store an eligible participant's own T cells for future use to make CAR T-Cell therapy for their disease treatment. Design: This is a non-interventional, observational study to evaluate participants with solid tumors with a high risk of relapse for incurable disease. No interventional therapy will be administered on this study. Some of the information regarding the participant's tumor analysis may be beneficial to management of their disease. Participants that meet all criteria may be enrolled and leukapheresed (blood cells collected). The participant's cells will be processed and stored for potential manufacture of CAR T-cell therapy upon relapse of their cancer.
Recruiting1 award N/A3 criteria
A2B694 CAR T-Cells
for Solid Cancers
This trial tests a new immune cell therapy for adults with difficult-to-treat solid tumors. The therapy modifies the patient's own immune cells to target and kill cancer cells while protecting healthy cells. The study aims to find a safe dose and see how well it works.
Recruiting1 award Phase 1 & 27 criteria
More about J. Randolph Hecht, MD
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments J. Randolph Hecht, MD has experience with
- CAR T-Cell Therapy
- A2B530
- A2B694
- LYL845
- Botensilimab
- Gemcitabine
Breakdown of trials J. Randolph Hecht, MD has run
Pancreatic Cancer
Lung Cancer
Colorectal Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does J. Randolph Hecht, MD specialize in?
J. Randolph Hecht, MD focuses on Pancreatic Cancer and Lung Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is J. Randolph Hecht, MD currently recruiting for clinical trials?
Yes, J. Randolph Hecht, MD is currently recruiting for 2 clinical trials in Santa Monica California. If you're interested in participating, you should apply.
Are there any treatments that J. Randolph Hecht, MD has studied deeply?
Yes, J. Randolph Hecht, MD has studied treatments such as CAR T-Cell Therapy, A2B530, A2B694.
What is the best way to schedule an appointment with J. Randolph Hecht, MD?
Apply for one of the trials that J. Randolph Hecht, MD is conducting.
What is the office address of J. Randolph Hecht, MD?
The office of J. Randolph Hecht, MD is located at: UCLA Medical Center, Santa Monica, California 90404 United States. This is the address for their practice at the UCLA Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.